Complement peptide C3a inhibits IgE-mediated triggering of rat mucosal mast cells.
The relationship between mast cells' secretory response to stimulation via their type 1 Fc epsilon receptors (Fc epsilon RI) and that provided by the C3a fragment of the complement system was investigated in the rat mucosal-type mast cell line RBL-2H3. These cells are known to be unresponsive to the so-called 'peptidergic' stimulus provided by cationic agents, such as anaphylatoxins, neuropeptides or polyamines. We now observed that C3a effectively inhibits the Fc epsilon RI clustering induced secretion of RBL-2H3 cells. This inhibition is dose-dependent and takes place at a C3a concentration range of 0.4-12.5 nM, i.e. at least three orders of magnitude lower than those where this anaphylatoxin exerts its secretory stimulus to 'serosal' mast cells. In order to identify where C3a interferes in the Fc epsilon RI coupling cascade, we have studied its effect on the cells' protein phosphorylation pattern, hydrolysis of phosphatidyl inositides, transient rise in free cytosolic Ca2+ ion concentration and Ca2+ uptake. All these processes were found to be inhibited by a similar C3a concentration range.
D000818:Animals; D002118:Calcium / Q000378:metabolism; D015550:Cell Degranulation; D002478:Cells, Cultured; D015926:Complement C3a / Q000494:pharmacology*; D006801:Humans; D007073:Immunoglobulin E / Q000502:physiology*; D008407:Mast Cells / Q000502:physiology*; D010716:Phosphatidylinositols / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D014443:Tyrosine / Q000378:metabolism
D010716:Phosphatidylinositols; D007073:Immunoglobulin E; D014443:Tyrosine; D015926:Complement C3a; D002118:Calcium